Somanta Pharmaceuticals, Inc. Signs Cancer Drug Development Agreement With University Of Bradford

Published: Sep 20, 2006

LONDON & IRVINE, Calif.--(BUSINESS WIRE)--Sept. 19, 2006--Somanta Pharmaceuticals (OTCBB:SMPM) today announced that the Company has signed a research collaboration agreement with the University of Bradford, Leed, United Kingdom, giving Somanta the rights to new data, inventions and discoveries in certain areas of cancer research at the University's Institute for Cancer Therapeutics (www.cancer.Brad.ac.uk).

Back to news